Therapeutics and Clinical Risk Management | Volume 12 - Dove Press
Nonhospitalized Adults: Therapeutic Management | COVID-19 Treatment Guidelines
Therapeutics and Clinical Risk Management | Volume 14 - Dove Press
Biological Risk Assessment: General Considerations for Laboratories
IJERPH | Special Issue : Clinical Risk Management: As Modern Tool for Prevention and Management of Care and Prevention Occupational Risk
Archive of "Therapeutics and Clinical Risk Management". - PMC
Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: A review - ScienceDirect
Risk Management | Astellas Pharma Inc.
Therapeutics and Clinical Risk Management - Dove Press
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 | NEJM
Fundamental & Clinical Pharmacology - Wiley Online Library
Risk Management Program | Molecular and Cellular Therapeutics
Integrating genetic and epigenetic factors in chronic myeloid leukemia risk assessment: toward gene expression-based biomarkers | Haematologica
Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
5 Successful Risk Scoring Tips to Improve Predictive Analytics
Therapeutics and Clinical Risk Management - Dove Press
Therapeutics and Clinical Risk Management – ScienceOpen
Hospitalized Adults: Therapeutic Management | COVID-19 Treatment Guidelines
Therapeutics and Clinical Risk Management | Journal metrics - Dove Press
Therapeutics and Clinical Risk Management | Volume 14 - Dove Press
Therapeutics and Clinical Risk Management – ScienceOpen
Therapeutics and Clinical Risk Management - Dove Press
Frontiers | The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19 | Immunology
The Impact of Sickle Cell Disease: Updates in Therapeutics, Treatment, Management, and Future Directions - European Medical Journal
Home Page ::: Current Pharmaceutical Biotechnology
